Skip to main content

Report: U.S. House To Vote On Cannabis Banking Bill Later This Month

In order for the emerging cannabis industry to reach its full potential comprehensive federal banking reform will be required. The legal cannabis industry in the United States is conducting billions of dollars worth of transactions annually, with a vast majority of them being cash-based.

Consumers would likely prefer to pay for their cannabis via electronic methods, similar to how they do with almost every other good and service. However, that is not an option in many cases.

Cannabis companies would prefer to be able to make deposits into bank accounts like every other legal business and pay their taxes with a check instead of huge bags of cash. Unfortunately, many cannabis companies have had their bank accounts involuntarily closed or were not allowed to open a bank account to begin with.

It’s a ridiculous situation that is born out of cannabis being prohibited at the federal level. Banking reform is desperately needed to help cannabis consumers and cannabis companies.

A reported vote in the House of Representatives is expected later this month on the SAFE Banking Act, which would help matters considerably. News regarding the expected vote was first reported by Marijuana Moment:

A bipartisan bill to protect banks that service marijuana businesses will get a House floor vote by the end of the month, the office of Majority Leader Steny Hoyer (D-MD) confirmed to Marijuana Moment on Friday.

House leadership announced the decision to Democratic lawmakers at a closed-door meeting on Thursday.

“Mr. Hoyer said at the Whip meeting yesterday that he intends to move it this month,” a Hoyer staffer said in an email. “We’re discussing it with Members, but it hasn’t been scheduled just yet.”

The SAFE Banking Act has bipartisan support in the House and is expected to pass if/when it is put to a vote. It’s unclear what the odds are of the bill passing if it eventually gets sent to the Senate.

Current political forces in the Senate have resulted in most bills that were passed by the House being dead on arrival once they get to Senator Mitch McConnell’s chamber. Will that be the case for this cannabis banking reform measure? Only time will tell.

Is Cannabis A Constitutional Question?

By Marguerite Arnold

As the discussion about cannabis access in Europe continues to progress, albeit slowly, based on the legislative mandates of lawmakers and regulatory policies driven by medical efficacy, there is an additional conversation afoot.

Namely, is the right to access affordable medical cannabis actually something more fundamental? In two countries, Canada and Mexico, this is the discussion that has actually driven the industry forward. In Canada, the constitutional right to medical access is what created the private medical market and then the recreational one beyond that.

In Mexico, where the Supreme Court first decided that patients had a constitutional right to access the drug several years ago, this summer the Court has ordered the Ministry of Health to issue much-stalled regulations within 6 months.

How different are these drivers than what is going on in the United States and Europe right now?

Is Medical Cannabis and Or Healthcare A Human Right?

The question about how access is framed depends on the domestic debate going on around you. For example, in Germany, patient access to cannabis was first decided by a patient lawsuit via a patient seeking to grow his own medicine when obtaining it from a pharmacy was cost-prohibitive.

However, because the right to grow cannabis was not enshrined into constitutional law, this right was taken away after the law was reformed in March 2017. Now German patients, theoretically, with health conditions that qualify for cannabis can try to get it covered by their health insurance.

Since not having health insurance is against the law, the legal construct in Germany is more or less that accessing cannabis, if you can convince your doctor to prescribe it and your insurer to cover it, is a basic, fundamental right of access that comes with sovereignty and or the right to live in the country legally – details and problems along the
way notwithstanding, starting with the fact that insurers are demanding proof of medical efficacy which does not exist yet.

In Canada, as the industry has learned, patients have fought hard to protect their right to cultivate, and this has been upheld, particularly because health insurance coverage for the drug is not mandatory.

In the United States, this political point of view is unwieldy and tied up with greater discussions about how the entire insurance coverage issue turns. Universal healthcare is contentious enough. It is unlikely, in other words, that the federal Constitution will be altered as states’ have done to ensure the progress of the industry.

In Mexico, it remains to be seen how the Supreme Court mandate over the Ministry of Health will fundamentally move the industry forward. There are bank regulations that must be dealt with, all of which depend on the greater acceptance of the U.S. banks that still face an uncertain discussion about cannabis.

However, if accessing cannabis is a human right, and the health department is forced to issue regulations about its use, perhaps the financial regulatory aspects of prohibition that have long held this issue back south of the border are finally on their way out too.

About International Cannabis Business Conference

International Cannabis Business Conference events are the premier cannabis events for entrepreneurs across the globe. With events in Canada, the United States, Switzerland, Spain, and Germany the International Cannabis Business Conference is where the world meets cannabis. Find out more at InternationalCBC.com and on Twitter, Facebook, and Instagram.

Thai Surprise: Country Warned By International Bodies Over Cannabis Liberalization Plans

By Marguerite Arnold

For all of its enthusiastic entry into the legal cannabis space of late, Thailand has also caught the attention of international regulators (specifically the International Narcotics Control Board INCB). In fact, the agency recently issued a warning to the government to go slow when it comes to bucking a century of prohibition.

Thailand has already been warned that if it decriminalizes cannabis for recreational use it might also lose import privileges for certain types of medicines.

While such dire threats were not issued when Luxembourg recently made international headlines for committing to cannabis reform measures, this is also mostly driven by the reality that Thailand, unlike Luxembourg, seems to be gearing up for both an export policy and an active tourist economy.

Then again, there are three international treaties at stake – namely the 1961 Single Convention on Narcotic Drugs, the Convention on Psychotropic Substances of 1971 and the Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988.

The warning comes at a time when the excitement about Thailand proceeding with cultivation licenses is increasing, however, the Public Health Ministry has yet to decide on a composition of a committee to oversee said production if not consumption downstream.

If this confusion sounds familiar, there is a reason. Every country, from Germany to Canada, has gone through a protracted, and often painful, internal and external rulemaking and implementation process.

In Germany for example, a country with a now formalized cultivation bid process, the German government seems more interested in importing flower across the border with Holland than tendering any domestically produced product for now (although a new bid round is also widely rumoured to be in the cards within the next 24 months).

In Canada, health regulators are now dealing with the extremely messy backlash due to moving too quickly into a regulated market that still allowed a major disaster like CannTrust to happen.

And those are just the “easy” examples.

South of the U.S. border, in particular, every attempt to liberalize drug policy and end the drug war has run into opposition from U.S. banks in addition to everything else. See both Mexico and Uruguay.

In summary, what Thailand is facing is no more, and no less, than official notification from bodies who have yet to catch up with the speed of events on the ground and that cannabis is still a highly stigmatized and controlled substance.

How the country adapts to such realities and learns from others now in similar circumstances (such as Greece) will be interesting to watch as another subchapter in reform now rolls into the history book.

Even in Asia.

About International Cannabis Business Conference

International Cannabis Business Conference events are the premier cannabis events for entrepreneurs across the globe. With events in Canada, the United States, Switzerland, Spain, and Germany the International Cannabis Business Conference is where the world meets cannabis. Find out more at InternationalCBC.com and on Twitter, Facebook, and Instagram.

Multiple Trump Administration Officials Speak Out Against Cannabis

Officials with the Trump administration spoke out against cannabis this week. First, the United States Surgeon General issued an advisory warning about the harms of cannabis consumption. “The legalization movement may be impacting youth perception of harm from marijuana,” the advisory stated.

The advisory was largely directed at pregnant women and adolescents and its publication will be partially funded by a $100,000 donation from President Donald Trump’s salary. It did not take long for the cannabis community to take issue with the approach that the United States Surgeon General is pursuing.

“It has long been acknowledged that cannabis is a mood-altering substance with some risk potential. In fact, it is precisely because marijuana use may pose potential risks to certain consumers — for example, adolescents or people with a family history of psychiatric illness — that NORML believes that lawmakers should regulate it accordingly.” NORML‘s Executive Director Erik Altieri stated in a press release in reaction to the Surgeon General’s advisory.

Altieri went on to say, “Our current model of federal prohibition represents the utter lack of control over any aspect of marijuana or the marijuana market. The Surgeon General’s time would be better spent advocating for a legally and tightly regulated cannabis market – one in which we educate Americans about the potential harms and benefits of cannabis through evidence-based public education campaigns – rather than through fear-mongering.”

Later in the day Trump cabinet official Alex Azar (Health and Human Services) was on Fox Business promoting the advisory, but in the process, inadvertently made the case for a regulated cannabis industry when he himself pointed out that the unregulated cannabis industry doesn’t have consumer labels, which would obviously help with addressing concerns about public health education.

Today’s comments by members of the Trump administration were well summed up by Morgan Fox from the National Cannabis Industry Association, as reported by Marijuana Moment:

“Despite a lot of misinformation and selective analysis being promoted by the surgeon general and HHS today, pretty much everything they said has bolstered the case for making cannabis legal and regulated at the federal level,” Morgan Fox, media relations director for the National Cannabis Industry Association, told Marijuana Moment. “Research, honest fact-based education, and effective public health resource allocation are all stymied by prohibition.”

About the International Cannabis Business Conference

International Cannabis Business Conference events are the premier cannabis events for entrepreneurs across the globe. With events in Canada, the United States, Switzerland, Spain, and Germany the International Cannabis Business Conference is where the world meets cannabis. Find out more at InternationalCBC.com and on Twitter, Facebook, and Instagram.

Trump Administration Wants Public Feedback Regarding International Cannabis Rescheduling

Back in March the United States Food and Drug Administration initially requested input from the public regarding international cannabis policy. The public input was meant to help the U.S. Department of Health and Human Services be prepared when working with the United Nations (U.N.).

At the time it was speculated that the U.N.’s Commission on Narcotic Drugs may be voting on cannabis recommendations, and thus the United States needed to be prepared to present its position. However, a vote never materialized.

The Food and Drug Administration is now re-opening a public comment period for the same matter. People will have a 30-day window in which to provide their comment(s), as first reported by Kyle Jaeger at Marijuana Moment:

The new notice about the move to take more public input is set to be published on Thursday. After that point, people will be able to submit comments electronically or through mail for a period of 30 days.

Rescheduling cannabis under the international treaties technically wouldn’t free up member countries to legalize it without being in strict compliance, but it would reflect an evolving understanding of the plant within one of the world’s most influential intergovernmental organizations. And even the UN’s current restrictive status for cannabis hasn’t stopped Canada and Uruguay from moving forward to end prohibition.

It will be very interesting to see what the Trump administration’s position ultimately ends up being. President Trump has made multiple statements in favor of federal reform over the years, both prior to becoming president and while in office, however, comprehensive reform has yet to occur.

Cannabis reform at the international level is way overdue. Canada and Uruguay have both legalized cannabis for adult-use and other countries such as Luxembourg are likely to follow in the not-to-distant-future. The international community needs to embrace the cannabis industry, not prohibit it.

International cannabis policy and industry will be at the top of the agenda at the upcoming International Cannabis Business Conference in beautiful Vancouver, British Columbia September 15-16. Whether you are a seasoned industry veteran or someone just starting to look into the endless opportunities that exist in the cannabis space, make sure to buy your tickets today and join us in Vancouver!

About the International Cannabis Business Conference

International Cannabis Business Conference events are the premier cannabis events for entrepreneurs across the globe. With events in Canada, the United States, Switzerland, Spain, and Germany the International Cannabis Business Conference is where the world meets cannabis. Find out more at InternationalCBC.com and on Twitter, Facebook, and Instagram.

US Cannabis Legalization: Sparking A Wave Of Liberalization Abroad

By: David Wenger

In the United States, we are seeing unprecedented momentum toward legalization of cannabis. 2019 has been a historic year for reform at the federal and state levels. As the US moves closer to legalizing cannabis, the rest of the world watches. And as the US reconciles federal cannabis legalization with international drug treaty obligations, a transformational precedent will be set.

After summarizing recent progress in the US, this article discusses how the US may harmonize federal legalization with international treaty obligations and the likely resulting impact abroad.

Unprecedented Progress Towards US Federal Cannabis Reform

At the federal level in the US, historic progress is being made in the 116th Congress toward legalizing cannabis. For the first time in more than three years, on June 20 the full US House of Representatives voted on a cannabis measure. The House passed by a large majority (267-165) the Blumenauer-McClintock-Norton Amendment (1) which would protect the legal cannabis industry from DOJ action. (2) A Senate vote is expected after the August summer recess.

Prospects are high for near-term passage of the SAFE Banking Act of 2019, which would protect banks, related entities, and insurers servicing cannabis companies from federal interference. The House version (3) has 206 co-sponsors, (4) just short of the 218 total votes required. The House Financial Services Committee voted 45-15 on March 28 to advance the banking bill to the full House for a vote. (5) The Senate version (6) has 31 co-sponsors, (7) nearly one-third of the Senate.

The Senate Committee on Banking, Housing, and Urban Affairs held a public hearing on the SAFE Banking Act on July 23. (8) After the hearing, Senator Cory Gardner (R-CO) said he was confident of sufficient support in the Senate: “[I]t would pass with majority support and I think it would have a majority of Republicans voting for it as well.” (9) On July 31, the Republican Chair of the Senate Banking Committee, Sen. Mike Crapo (ID), called for ending banking restrictions on cannabis companies. (10) Through the SAFE Banking Act, Congress has an opportunity to not only protect banks and insurers that would serve the industry but also protect US stock exchanges that would list US cannabis companies. (11)

This Congress has been described as the “most marijuana-friendly Congress in history.” (Tom Angell). (12) Justin Strekal, NORML’s political director, said: “Congress has never moved this far, this fast on marijuana policy, period.” (13) Only seven months into this Congress, there have already been seven cannabis hearings. (14)

Previously-introduced federal bills are gaining support, as new federal legislation is introduced. (15) Bills such as the STATES Act (16) and the Marijuana Freedom Opportunity Act (17) are joined by recent bills such as one filed on July 31 by the second-highest ranking Democratic senator, Dick Durban (IL). (18) Democratic presidential contenders Sen. Kamala Harris (D-CA), Sen. Cory Booker (D-NJ), and Sen. Elizabeth Warren (D-MA), and House Judiciary Committee chair Rep. Jerrold Nadler (D-NY) have all sponsored legislation to legalize cannabis. (19)

Republican Senate Majority leader Mitch McConnell has not publicly supported federal cannabis reform (he remains an unknown for passage of the SAFE Banking Act). However, an interesting dynamic has developed. Senator McConnell has expended significant political capital to pass the Farm Bill legalizing hemp in December 2018, for some of his staunchest supporters in the Kentucky hemp industry. (20) But the FDA has not yet acted to provide regulatory pathways for many hemp-derived products. (21) Senate Democrats, such as Senators Ron Wyden and Jeff Merkley (both OR), and representatives on the House Small Business Committee, have already publicly urged the FDA to move forward. (22) Democrats in Congress focused on legalizing cannabis could join forces with McConnell and his Republican counterparts to urge the FDA to move forward, in exchange for McConnell and his allies agreeing to tacitly support or at least stand down from opposing federal cannabis legalization.

While Democratic presidential candidates challenge each other over cannabis reform credibility and who will most strongly support legalization, (23) President Trump waits for an opportune moment to indicate his support, for maximum political advantage. He will not go unchallenged on cannabis reform in the election runup. And he has given every indication in public and in known private conversations of his views on States’ rights with regard to cannabis reform. (24)

Significant Progress At The US States Level

At the state level, across the country there is also significant progress toward reform of medical and adult-use legislation. While there have been setbacks where legislators failed to implement the public will—including in New York where Governor Cuomo did not timely and adequately support adult-use legalization (25) and in New Jersey with opposition from some legislators whose constituents suffer the most from the war on drugs (26) —states such as Illinois and Michigan have seized an opportunity to implement pragmatic, corrective, inclusive adult-use legislation.

In 2020, Illinois (the first state to legalize adult-use through the legislature) and Michigan will have two large urban areas (metro Chicago and Detroit, combined population of 14 million) with legalized adult-use marketplaces. They will garner enormous tax revenues, and in time eclipse Colorado which has already collected more than $1 billion in cannabis tax revenues. (27) In Massachusetts, the marketplace is expanding, reaching more than $140 million in the first six months and expected to reach up to $500 million this year, (28) joining states like California, Nevada, Washington, and Oregon selling billions of dollars of legal cannabis. In states like Maine and Vermont, where adult-use cannabis is legal but not sold in regulated, state-revenue-generating stores, officials are seriously discussing a legalized, regulated marketplace. (29) States such as Florida and Oklahoma are seeing rapid expansion of their medical cannabis programs. (30) Opposition to sensible cannabis reform is largely based on ignorance or is financially motivated – in addition to the enormous tax revenues regulated markets are realizing, social impacts in legalized adult-use states have been at worst neutral and generally positive, with reports of
falling crime rates, (31) reduced youth usage, (32) reduced alcohol intake, (33) and significant reductions in prescription medication usage especially opioids. (34)

Adult-Use Cannabis Is Strictly Prohibited Under The UN Single Convention

As the US progresses towards legalization on the federal level, with growing state marketplaces, examination is warranted of the US’ international obligations under the 1961 UN Single Convention on Narcotic Drugs (the “Single Convention,” as amended by the 1972 Protocol). (35) Under Article 4 of the Single Convention, (36) the production, manufacture, export, import, distribution of, trade in, use and possession of cannabis is expressly limited “exclusively to medical and scientific purposes.” (37) Adult-use cannabis is strictly prohibited. Cannabis is placed under the strictest of the control schedules; it is considered among the most dangerous of all psychoactive substances under international control. (38)

Advances in global cannabis legislative reform contrary to the Single Convention have not gone unnoticed by the International Narcotics Control Board (“INCB,” an independent body that monitors Governments’ compliance with international drug control treaties). (39) INCB has proclaimed that Canada’s legalization of adult-use cannabis is “inconsistent” with the Convention. (40) The INCB has also said that existing drug treaties provide zero “wiggle room,” such that the strict prohibition against non-medical use applies fully to states within federal structures of government: namely, US states legalizing adult-use is inconsistent with Convention obligations. (41) In response, US officials have argued that since the cultivation, trade, and possession of cannabis remain criminal offenses under US federal law, the federal government as a State party is not in breach. (42)

Reconciling US Federal Legalization With The Single Convention: Inter Se Modification

While a federalism-grounded distinction may be acceptable for now, the US is unlikely to legalize cannabis federally for adult-use, as Canada has, without addressing its Single
Convention obligations. The US was the chief architect of the Convention, including placing cannabis under the strictest control measures. (43) The US government has long been the most ardent champion of the drug treaties, and the foremost proponent of full and vigorous implementation. (44) When Congress revises federal law to formally accommodate regulated cannabis, the federal versus states legislative distinction will no longer be possible. (45)

Revision of the UN Single Convention to accommodate an updated federal regulatory regime in the US allowing for adult-use cannabis would be difficult. Although formal mechanisms for revision exist, the reality is no substantive changes would likely be made on anything other than non-controversial issues. An amendment of the schedules to remove cannabis would require a recommendation by the WHO’s Expert Committee on Drug Dependence followed by a majority vote by 53 member States (46) of the UN Commission on Narcotic Drugs. (47)

A more likely alternative through which the US may reconcile its Convention obligations is by inter se modification permitted under Article 41 of the Vienna Convention on the Law of Treaties (“VCLT”). (48) Under the inter se modification option, like-minded parties may enter into inter se agreements permitting the production, trade and consumption of cannabis for non- medical and non-scientific purposes while remaining compliant with the Convention. A Swansea University report titled “Balancing Treaty Stability and Change: Inter se modification of the UN drug control conventions to facilitate cannabis regulation” (March 2018) explores the rationale, legitimacy, and feasibility of the inter se option for modification of Convention obligations. (49)

Under Article 41 of the VCLT, inter se modification is permissible if: (a) ‘the possibility of such a modification is provided for by the treaty’ or (b) when ‘the modification is question is not prohibited by the treaty and (i) does not affect the enjoyment by the other parties of their rights under the treaty or the performance of their obligations; or (ii) does not relate to a provision, derogation from which is incompatible with the effective execution of the object and purpose of the treaty as a whole.’ (50) In other words, because inter se modification is not provided for by the Convention, it would be available under VCLT Article 41 if enjoyment by the other parties of their rights and performance of their obligations is not affected, or if the effective execution of the object and purpose of the treaty as a whole would not be immediately compromised if one or more parties decide to regulate the sale and supply of cannabis for adult-use purposes.

An inter se agreement would need to be based on domestic markets that are isolated from non-parties to the inter se agreement. (51) A strictly controlled legal regulated market in some jurisdictions is likely to prove more effective in preventing the illicit export of cannabis from those regulated jurisdictions in comparison to the current situation because state controls over the substance are likely to be tighter and more widely respected than is currently the case. (52) Thus, a legally regulated market existing in states that are parties to the inter se agreement would not only not adversely affect non-parties to that agreement, but may well benefit non-parties.

The Swansea University report posits that the option of inter se modification holds enormous promise and merits careful consideration for application by like-minded States. (53) The report concludes that the possibility of inter se modification was specifically designed to find a balance between the stability of treaty regimes and the necessity of change in absence of consensus in order to respond to the changing social conditions in member States. (54) The report argues that the circumstances in which the UN drug control treaty regime finds itself today—systemic challenges and inconsistencies, increasing tensions with State practices, huge political and procedural obstacles to amendments, and unilateral escape attempts—merit careful consideration of the inter se modification option. (55)

Modification Of Convention Obligations Will Spark A Wave Of Legalization

When the US Congress is seriously considering legalizing cannabis federally, perhaps within 12 to 18 months, the entire North America will be close to having legal adult-use cannabis. As early as September 2019, the Mexico Senate will be discussing legalizing cannabis and the Senate has set a deadline of October 25, 2019 to approve new cannabis legislation. (56) Thus, a distinct possibility emerges of an inter se agreement negotiated amongst the North American nations that allows for regulated cannabis commerce within and between them, but also consistent with Single Convention obligations.

Should North American nations work toward entering an inter se agreement regulating cannabis commerce amongst themselves, that would spark a wave of cannabis legalization across Europe and elsewhere. Countries such as Germany, Switzerland, Spain, Portugal, the Czech Republic, and other EU nations, along with Colombia, Israel, Thailand, and many others, could very likely want to join such an agreement, laying the foundation for a global cannabis industry. The US started and fueled the global war on marijuana; when the US stands down, much of the rest of the world led by Europe will follow suit. The EU market for cannabis will be enormous – forecasted at €123B by 2028, including a €65 billion adult-use market. (57) Progress is already being seen in Europe toward legalization, including advances in medical cannabis legislation throughout the continent, (58) Swiss and French government advisory commissions calling for adult-use legalization, (59) support for legalization among rising German political parties, (60) and Luxembourg poised to enact adult-use legalization. (61) But in Europe, major progress awaits what will happen across the Atlantic.

***
The trajectory is clear, even if the timing is uncertain. As legalization advances, and the cannabis industry spreads from the Americas to Europe and beyond, the future of global cannabis commerce will present formidable challenges but also incredible opportunities for those with the foresight and ability to execute on a generational opportunity.

Citations

1 H. Amdnt. 398. https://www.congress.gov/amendment/116th-congress/house-amendment/398/text.
2 http://clerk.house.gov/evs/2019/roll370.xml; https://www.forbes.com/sites/tomangell/2019/06/20/congress-votes-to-block-feds-from-enforcing-marijuana-laws-in-legal-states/#74018cf84b62. Aaron Smith, executive director of the National Cannabis Industry Association, called the vote “without a doubt the biggest victory for federal cannabis
policy reform to date, and a hopeful sign that the harmful policies of marijuana prohibition will soon be a relic of the past.” Id.
3 https://www.congress.gov/bill/116th-congress/house-bill/1595/text.
4 https://www.congress.gov/bill/116th-congress/house-bill/1595/cosponsors.
5 https://www.covfinancialservices.com/2019/04/house-financial-services-committee-passes-cannabis-banking-bill/.
6 https://www.congress.gov/bill/116th-congress/senate-bill/1200/text.
7 https://www.congress.gov/bill/116th-congress/senate-bill/1200/cosponsors.
8 https://www.natlawreview.com/article/senate-holds-public-hearing-banking-access-cannabis-industry.
9 https://www.marijuanamoment.net/watch-live-senate-committee-holds-hearing-on-resolving-marijuana-banking-issues/
10 https://www.wikileaf.com/thestash/gop-chair-end-marijuana-banking-restrictions. He said: “I think all the issues got well vetted. We now need to, I think, move forward and see if there’s some way we can draft legislation that will deal with the issue.” Id. Senator Crapo repeated this sentiment again on August 8: “There are serious questions that I
have recognized need to get resolved. I am looking at that issue on a federal level.” https://www.postregister.com/star/ news/crapo-talks-marijuana-health-care-in-grant-park/article_ecd0364d-d620-5024-b521-647e0d0e449c.html.
11 The situation now is that US cannabis companies paying millions of dollars in federal taxes, with thousands of employees in the US, and building infrastructure across the country cannot access our capital markets, but Canadian cannabis companies with no operations here and paying no federal taxes have raised billions of dollars on the US capital markets. See https://www.newcannabisventures.com/proposed-federal-legislation-could-open-major-exchanges-to-american-cannabis-companies/.
12 https://www.forbes.com/sites/tomangell/2019/07/31/this-is-the-most-marijuana-friendly-congress-in-history/#778ea5bd672f.
13 Id.
14 Id. On June 19 the House Small Business Committee held a hearing on challenges for small business. https://www.marijuanamoment.net/watch-live-congressional-committee-discusses-challenges-for-small-marijuana-businesses/. On July 10 the House Judiciary Subcommittee on Crime, Terrorism, and Homeland Security held a hearing on ending prohibition and the racial impacts of marijuana laws. https://www.marijuanamoment.net/watch-live-congress-holds-historic-hearing-on-ending-federal-marijuana-prohibition/.
15 On August 12, the American Bar Association issued a resolution urging Congress to remove cannabis from Schedule 1 of the Controlled Substances Act to address the “regulatory quagmire” resulting from conflicting federal and state cannabis laws. https://www.marijuanamoment.net/american-bar-association-urges-congress-to-let-states-set-their-own-marijuana-policies/.
16 https://www.congress.gov/bill/116th-congress/house-bill/2093.
17 https://www.congress.gov/bill/116th-congress/senate-bill/1028.
18 https://www.marijuanamoment.net/top-democratic-senator-files-bill-to-reschedule-and-research-marijuana/; He had previously called Illinois’ medical cannabis program “almost a laughing matter.” Id.
19 https://www.harris.senate.gov/news/press-releases/harris-nadler-introduce-comprehensive-marijuana-reform-legislation; https://www.booker.senate.gov/?=press_release&id=892;
https://www.warren.senate.gov/newsroom/press-releases/senators-warren-and-gardner-reintroduce-bipartisan-bicameral-legislation-to-protect-states-marijuana-policies.
20 On August 14, Senator McConnell wrote an Op-Ed stating: “Whatever obstacles Kentucky hemp farmers, processors and manufacturers might encounter as they try to take full advantage of this hemp revolution, I’ll be there to help in any way I can. https://www.marijuanamoment.net/mitch-mcconnell-checks-in-on-hemp-legalizations-progress-op-ed/.
21 As compared to other products the FDA regulates and are widely available such as pharmaceuticals, alcohol, and high-sugar food, which lead to deaths every day through overuse, there is not a single known case of a CBD- or cannabis-caused death.
22 https://www.lexology.com/library/detail.aspx?g=048bd5f8-3704-4583-811d-ab6fa4d251d4; https://www.marijuanamoment.net/lawmakers-push-federal-agencies-to-free-up-the-cbd-industry/
23 https://www.bostonglobe.com/news/marijuana/2019/08/01/democratic-presidential-candidates-clash-marijuana-during-second-night-debate/41o10H9gUhTS8m6NEScm2H/story.html
24 See “The Green Regulatory Arbitrage,” available at https://www.newcannabisventures.com/wp-content/uploads/2018/09/The-Green-Regulatory-Arbitrage-Wenger-2018.pdf, pgs. 30-32.
25 Now, New Yorkers are spending millions of dollars buying cannabis in Massachusetts. https://www.leafly.com/news/industry/the-massachusetts-cannabis-market-is-booming-thanks-to-new-york
26 https://patch.com/new-jersey/bloomfield/new-jersey-senator-has-worries-legal-weed-do-you-agree
27 https://www.cnbc.com/2019/06/12/colorado-passes-1-billion-in-marijuana-state-revenue.html
28 https://mjbizdaily.com/massachusetts-recreational-marijuana-sales-approach-140-million/
29 https://www.pressherald.com/2019/06/27/mills-signs-marijuana-regulations-into-law/; https://mjbizdaily.com/vermont-house-committee-moves-commercial-adult-use-marijuana-bill-forward/.
30 https://mjbizdaily.com/medical-marijuana-market-growth-with-oklahoma-and-florida-leading/.
31 https://www.forbes.com/sites/janetwburns/2018/01/16/violent-crime-has-fallen-in-border-states-with-legal-cannabis-study/.
32 https://www.marijuanamoment.net/federal-data-shows-youth-marijuana-use-isnt-increasing-under-legalization/,
33 https://www.forbes.com/sites/thomaspellechia/2018/01/22/alcohol-sales-dropped-15-percent-in-states-with-medical-marijuana-laws/.
34 https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-019-0278-6; https://drugabuse.com/study-medical-marijuana-cuts-use-of-prescription-drugs/; Tom Adams, managing director of preeminent cannabis industry intelligence data firm, BDS Analytics, told me that the most eye-opening statistic in his years of analyzing the cannabis industry is the degree of the use of cannabis as a replacement for traditional medication.
35 https://www.unodc.org/documents/commissions/CND/Int_Drug_Control_Conventions/Ebook/The_International Drug_Control_Conventions_E.pdf. Two additional other international treaties prohibit commerce in cannabis for recreational purposes by virtue of the scheduling of cannabis under the Single Convention – the Convention on Psychotropic Substances (1971) and the Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic Substances (1998). Id.
36 Signed by 186 member states, https://treaties.un.org/Pages/ViewDetails.aspx?src=TREATY&mtdsg_no=VI-18&chapter=6&lang=en.
37 Id. at pg. 30.
38 http://fileserver.idpc.net/library/stability_change-inter_se_mofication_gdpo-tni-wola_march_2018.pdf at pg. 3. The double-listing of cannabis in the Single Convention is reflective of how strictly it is treated. Cannabis, cannabis resin, and extracts and tincture of cannabis are in Schedule I among substances that present a serious risk of abuse
and are subject to all control measures envisaged by the Convention. Cannabis and cannabis resin are also listed in Schedule IV, along with another fifteen substances that are already listed in Schedule I and are deemed particularly dangerous by virtue of what are regarded to be their harmful characteristics, risk of abuse and extremely limited
therapeutic value. Id. at pg. 36, n. 9.
39 https://www.incb.org/incb/en/about.html.
40 http://fileserver.idpc.net/library/stability_change-inter_se_mofication_gdpo-tni-wola_march_2018.pdf at 3.
41 Id. at pg. 4.
42 Id. at pg. 8.
43 Id.
44 Id.
45 Id. at pg. 9.
46 https://www.unodc.org/unodc/en/commissions/CND/Membership/Membership.html.
47 http://fileserver.idpc.net/library/stability_change-inter_se_mofication_gdpo-tni-wola_march_2018.pdf at pgs. 14, 33.
48 https://treaties.un.org/doc/Publication/UNTS/Volume%201155/volume-1155-I-18232-English.pdf at pg. 342.
49 http://fileserver.idpc.net/library/stability_change-inter_se_mofication_gdpo-tni-wola_march_2018.pdf
50 https://treaties.un.org/doc/Publication/UNTS/Volume%201155/volume-1155-I-18232-English.pdf at pg. 342.
51 http://fileserver.idpc.net/library/stability_change-inter_se_mofication_gdpo-tni-wola_march_2018.pdf at 28.
52 Id.
53 Id. at pg. 34.
54 Id.
55 Id.
56 https://themazatlanpost.com/2019/07/26/mexico-recreational-use-of-marijuana-will-be-addressed-in-september-in-the-senate/; https://themazatlanpost.com/2019/08/09/mexico-senate-october-25-deadline-to-approve-marijuana-regulation/.
57 https://www.amp-eu.com/eurozone-cannabis-market-highlights-2018-and-beyond/; https://prohibitionpartners.com/wp-content/uploads/2019/07/The-European-Cannabis-Report-4th-Edition.pdf.
58 https://labiotech.eu/sponsored/medical-cannabis-europe-brexit/.
59 https://www.swissinfo.ch/eng/drug-debate-_swiss-health-commission-calls-for-legalisation-of-cannabis–/44930586; https://internationalcbc.com/french-government-tasked-commission-urges-cannabis-legalization/.
60 https://www.spiegel.de/international/germany/german-green-party-leads-in-public-opinion-polls-a-1272530.html; https://fortune.com/2019/07/19/europe-cannabis-canada/.
61 https://www.analyticalcannabis.com/articles/luxembourg-set-to-become-europes-first-recreational-cannabis-country-311735.

Luxembourg On Track To Legalize By 2022

Written By: Marguerite Arnold

Luxembourg Throws Down Gauntlet On European Cannabis Legalization

Luxembourg is going to disrupt the European cannabis industry. This summer, Luxembourg ‘s Health Minister confirmed that the country is now moving even faster toward full cannabis legalization and plans to release its first draft of plans for legalization by the end of 2019. If this project stays on schedule, Luxembourg will have Europe’s first fully legal recreational cannabis market by the beginning of 2022. So now the race begins. If Luxembourg is going to be the “Colorado of Europe”, who will be the “Washington State”, or even the “California” of European cannabis?

A Domestic Market For Locals Or A Tourist Mecca?

Luxembourg is clearly intent on setting the recreational cannabis agenda across the continent. And while excitement is growing, investments have been slow, because there are challenges.

Yes, Luxembourg has decided to drive the cannabis agenda, which means raising this issue to the EU level and creating a deadline. However, there are a couple of things industry investors should keep in mind:

  1. Luxembourg itself is a tiny country with just over half a million residents.
  2. The cannabis legalization plan so far is being pitched as an anti-crime, public health measure. Attracting throngs of cannabis infused tourists (and their piles of cannabis infused money) isn’t on the agenda.
  3. While international cannabucks are welcome there is an increasing sense that international investors aren’t the only game in town. Local production and local ownership are on the drawing board.

What Will The Market Look Like?

There has been alot of back and forth consulting between Luxembourg and Canada. Regulatory similarities ( like a proposal to limit personal possession to 30 grams, same as in Canada) are beginning to emerge. Expect a push to allow medical cannabis patients to grow their own medicine, while recreational users will have to buy weed at the store. For some reason, the cannabis hates the idea of people being allowed to grow their own weed, even though people can make their own beer yet commercial beer makers are doing fine. The fight, er, discussion about just who will have the right to produce cannabis is just beginning.

The game is in the early stages, and the players are just getting warmed up. But Luxembourg has announced the beginnings of a plan and set a deadline. As the dominoes start to fall, we wonder: Which country will be next?

 

The International Cannabis Business Conference is the best industry event to learn the latest and to network with top investors and entrepreneurs. Next up: Vancouver, Canada, this September 15-16, featuring top experts in the field, PLUS a performance on a luxury yacht by Cypress Hill’s DJ Muggs at the after party. Don’t delay, purchase tickets today! 

UK MPs Expect to Legalize Cannabis Within the Next 5 to 15 Years

Three United Kingdom Members of Parliament, representing the Conservative, Labour, and Liberal Democrat parties all recently traveled to Canada on a fact-finding trip organized by the harm reduction group Volte Face and all came back proclaiming that the UK would legalize cannabis in the coming years. The three MPs had different opinions on how soon their nation would end prohibition, somewhat along stereotypical party lines. Labour’s David Lammy and the Liberal Democrats’ Norman Lamb predicting that legalization could be implemented within the next five years while Conservative Jonathan Djanogly stated that it would take 10 to 15 years to follow Canada’s lead. Lammy, the MP for Tottenham, has now gone against the Labour Party’s official stance on cannabis, writing in The Guardian about why Britain should legalize and improve upon Canada’s model:

On a trip to Toronto, filmed by the BBC for a short documentary being shown on Monday, I was able to see the world’s largest regulated market up close. Production occurs in sterile grow-houses filled to the ceiling with the green plants. Licensed stores, protected by security guards, sell a wide range of cannabis strains in air-conditioned surroundings that appear somewhere between a vape shop and a pharmacy. The THC and CBD levels are marked on labels like the alcohol content on a bottle of beer. Touchscreens allow users to choose between oils, leaf, pre-rolls and pills as easily as picking between a Quarter Pounder or chicken nuggets in McDonald’s.

The potential benefits of legal regulation go beyond hurting the bank balances of criminal gangs and reducing the disproportionate criminalisation of certain groups. In the UK, children find it easier to access cannabis than alcohol. Taking cannabis out of the hands of street dealers and putting it behind the counter in shops with security guards and ID requirements would help protect those under 18. For adult users, there would be more mellow alternatives to the super-strength skunk linked most closely to psychosis, which currently makes up around 94% of the black market. Regulation means we can control and lower the average THC levels significantly, reducing mental health concerns.

The biggest challenge is to make the regulated market attractive enough to beat the black market, but not to glamorise it in a way that will increase consumption. If implemented correctly, legal regulation should reduce social and health harms to a minimum. Bill Blair, the former Toronto police chief turned Liberal minister in Canada, has had the job of trying to find this Goldilocks point in Canada. At present, he has not achieved it. The price of legal cannabis is around $10 (£6) a gram, compared to $6.37 in the illicit market. There are too few dispensaries for many users to have access. As a result, the majority of weed in Canada is still sold illegally.

Whether it takes the UK five years to end cannabis prohibition, or up to fifteen years, a majority of the people and politicians know that legalization is coming. It’ll still take a lot of hard work from advocates, but there is simply no way that British citizens, businesses, and policy makers will stand around and watch other nations across the globe bring more freedom, jobs, and revenue to their shores, without eventually deciding that prohibition’s time to end has come.

The International Cannabis Business Conference is THE industry event to learn the latest and to network with top investors, entrepreneurs, and advocates. Next up: Vancouver, British Columbia, Canada, this September 15-16. Purchase discounted early bird tickets by August 21st to save. 

International Cannabis Business Conference Vancouver Features a Yacht After Party Headlined by DJ Muggs of Cypress Hill!

The International Cannabis Business Conference returns to beautiful Vancouver, British Columbia, Canada, this September 15-16, with our trademark blend of business, politics, and culture. If you want the latest information on rules and regulations in Canada and around the world and to network with top investors, entrepreneurs, and advocates, the International Cannabis Business Conference is THE industry event for you. But the International Cannabis Business Conference doesn’t just educate, we also ensure that you are engaged and entertained, and our networking events, including our after parties, have become legendary around the world. This year in Vancouver, the after party will be taken to another level as Cypress Hills’ DJ Muggs will be performing on a yacht!

A VIP reception on the 15th will kick off the networking at International Cannabis Business Conference in Vancouver, as speakers, sponsors, and attendees gather at the Westin Bayshore Hotel. On the 16th, attendees will hear from industry experts on a host of important topics including: local Vancouver and B.C. regulations; regulations regarding edibles, topicals, concentrates, and extracts; mergers and acquisitions; domestic investments; going public; succeeding as a craft cannabis company; exporting internationally; extraction science and technology; and how to best develop strategic partnerships.

Following the conference curriculum, the exclusive after party, sponsored by Bhang and Indiva, will take place on a Pacific Yachts 105-foot, three-level luxury vessel. The yacht will be docked at the Westin Bayshore Hotel for an amazing party experience that will also be extremely convenient.

DJ Muggs, along with all of Cypress Hill, has been a long-time supporter of cannabis legalization, making music for the community, way before it was easy and popular. The group even lit up on Saturday Night Live, earning a lifetime ban from NBC! Today, Muggs and Cypress Hill are members of the cannabis industry, with an understanding of the ups and downs facing the community.

Join us this September 15-16 for an industry event like no other. Get your discounted early bird tickets by August 21st to secure your spot and to save $$$.